Great news from our local network of doctors.
Austin American Statesman article
"This is the most compelling development in breast cancer in the last five years," she said. "I had a patient come here from Puerto Rico to get access to this trial."
"Breast cancer experts not connected to the study greeted the results with excitement mixed with caution. For a cancer that is difficult to treat, iniparib shows great potential — provided the results are confirmed by the final, phase 3 trial, they said. Patients are still in that trial, and results will be out later this year, Patt said.